NOVO-TETRA SUS 125MG/5ML 125 MG / 5 ML
TETRACYCLINE HYDROCHLORIDE : 125 MG / 5 ML · DIN 00151416 · NOVOPHARM LIMITED
Health Canada status: CANCELLED POST MARKET
What is NOVO-TETRA SUS 125MG/5ML?
NOVO-TETRA SUS 125MG/5ML 125 MG / 5 ML contains TETRACYCLINE HYDROCHLORIDE : 125 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 00151416, held by NOVOPHARM LIMITED, supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Aug-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is NOVO-TETRA SUS 125MG/5ML called?
The same molecule, TETRACYCLINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| TETRACYCLINE LAPROPHAN | Latin | Morocco |
| TETRACYCLINE | Latin | Lebanon |
| DUMOCYCLINE EYE OINT | Latin | Saudi Arabia |
| HOSTACYCLINE | Latin | Morocco |
| OPTICYCLIN | Latin | United Arab Emirates |
| TEPHACYCLINE | Latin | Morocco |
| TERACIN | Latin | Saudi Arabia |
| Tetracycline Hci | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 00151416 |
|---|---|
| Brand name | NOVO-TETRA SUS 125MG/5ML |
| Generic / active ingredient | TETRACYCLINE HYDROCHLORIDE : 125 MG / 5 ML |
| Manufacturer | NOVOPHARM LIMITED |
| Strength | 125 MG / 5 ML |
| Dosage form | LIQUID |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01AA07 TETRACYCLINE |
| AHFS class | 08:12.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Aug-2005 |
| Original market date | 1967-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 00151416 |
|---|---|
| DIN (unpadded, as printed on some documents) | 151416 |
| Brand name | NOVO-TETRA SUS 125MG/5ML |
| Active ingredient / INN | TETRACYCLINE HYDROCHLORIDE : 125 MG / 5 ML |
| ATC code | J01AA07 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01 |
| AHFS class | 08:12.24 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | NOVOPHARM LIMITED |
Which pack is which?
| Strength on the label | 125 MG / 5 ML |
|---|---|
| Dosage form | LIQUID |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Is TETRACYCLINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by AA PHARMA INC (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code J01AA07 TETRACYCLINE. 1 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TETRACYCLINE | 250 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00580929 |
| ACHROMYCIN V CAP 250MG | 250 MG | CAPSULE | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00014605 |
| APO TETRA TABS 250MG | 250 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00603252 |
| JAA TETRA TAB 250MG | 250 MG | TABLET | JAAPHARM CANADA INC. | CANCELLED POST MARKET | DIN 00889393 |
| MEDICYCLINE CAP 250MG | 250 MG | CAPSULE | MEDIC LABORATORY LTÉE | CANCELLED POST MARKET | DIN 00134406 |
| NOVO-TETRA 250MG | 250 MG | CAPSULE | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00021059 |
| NOVO-TETRA 250MG | 250 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00021806 |
| NU-TETRA CAPSULES 250MG | 250 MG | CAPSULE | NU-PHARM INC | CANCELLED POST MARKET | DIN 00717606 |
| TETRACYCLINE CAP 250MG | 250 MG | CAPSULE | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00156744 |
| TETRACYCLINE CAP 250MG | 250 MG | CAPSULE | DUCHESNAY INC | CANCELLED POST MARKET | DIN 00448729 |
Who else supplies TETRACYCLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TETRACYCLINE appears in 24 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does TETRACYCLINE cost around the world?
TETRACYCLINE is listed on 8 national price registers Nexara tracks, across 40 pack listings published on 7 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 2 | 14 | 03 Sep 2026 |
| Saudi Arabia | public | 13 | 13 | 01 Sep 2026 |
| Morocco | PPV (public price) | 4 | 6 | 05 Sep 2026 |
| Greece | producer price (ex-factory) | 2 | 2 | 03 Sep 2026 |
| Lebanon | public price (USD, Decision 119/1) | 1 | 2 | 02 Sep 2026 |
| United Arab Emirates | public | 1 | 1 | 31 Aug 2026 |
| United Kingdom | hospital | 1 | 1 | 31 Aug 2026 |
| South Africa | single exit price | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.